The Skin Anti-Aging Mechanisms of α-Lipoic Acid: ALA/DHLA Redox Cycling, the Antioxidant Network, and Regulation of Collagen AGE Formation
The Skin Anti-Aging Mechanisms of α-Lipoic Acid: ALA/DHLA Redox Cycling, the Antioxidant Network, and Regulation of Collagen AGE Formation
1. The Chemical Basis Behind Dullness, Roughness, and Loss of Skin Elasticity
1.1 “Glycation Face” as a Manifestation of Glycation-Related Aging
“Glycation face” or “sugar face” is commonly used to describe skin conditions such as dull yellowish tone, rough texture, reduced elasticity, more visible fine lines, and diminished radiance. These visible changes reflect aging manifestations that arise from the combined involvement of glycation reactions, oxidative stress, inflammatory signaling, and structural changes in collagen within the skin.
At the core of glycation is a non-enzymatic reaction between reducing sugars or reactive carbonyl compounds and amino groups on proteins, lipids, or nucleic acids, ultimately leading to the formation of AGEs, or advanced glycation end products. In the skin, AGEs can affect collagen, elastin, keratinocytes, fibroblasts, and skin barrier function, and are associated with yellowing of the skin, reduced elasticity, and deeper wrinkles.
1.2 Glycation and Oxidation Jointly Drive AGE Formation
Skin glycation is not a single reaction, but a series of slow chemical changes. It begins with early-stage reversible reactions and gradually progresses into more stable, more difficult-to-reverse crosslinking stages.
Reducing sugar + protein-NH2
↓
Schiff base
↓
Amadori product
↓ Oxidation, dehydration, cleavage
Reactive dicarbonyl compounds: MGO (methylglyoxal); GO (glyoxal); 3-DG (3-deoxyglucosone)
↓
AGE formation
↓
Protein crosslinking, denaturation, and functional decline
During the glycation process, oxidative stress accelerates the conversion of intermediate products into AGEs. Metal ion-catalyzed oxidation reactions can also increase the generation of reactive carbonyl compounds. Skin glycation-related aging is therefore the result of glycation stress and oxidative stress acting together on structural proteins in the skin.
2. The Essence of Collagen Aging: Abnormal Crosslinking Makes Elastic Structures Stiffer
2.1 Collagen Aging Is Not Simply a Reduction in Quantity, but a Decline in Structural Quality
Collagen is the main structural scaffold of the dermis. A young collagen network has a certain degree of extensibility, sliding capacity, and rebound ability. Whether the skin appears firm and elastic depends not only on the amount of collagen, but also on whether collagen fibers maintain normal alignment and mechanical mobility.
AGEs can form abnormal crosslinks between collagen molecules, turning an originally flexible collagen network into a stiffened structure. This process can be understood as the gradual fixation of collagen architecture.
Normal collagen network
Collagen fiber —— Collagen fiber —— Collagen fiber
Extensible Able to slide Able to rebound
Collagen network after AGE crosslinking
Collagen fiber == AGE crosslink == Collagen fiber == AGE crosslink == Collagen fiber
Restricted sliding Reduced elasticity Structural stiffness
Skin collagen is a low-turnover, long-lived structural protein with a relatively slow renewal rate. Once AGEs, or advanced glycation end products, accumulate in collagen, they may cause long-term changes in the structural stability and mechanical properties of the dermal matrix. Studies show that AGEs such as CML (carboxymethyllysine), CEL (carboxyethyllysine), and pentosidine in skin collagen increase with age. Among them, CML and CEL are commonly used as non-crosslinking glycation markers, while pentosidine is a typical fluorescent crosslinking AGE. Because collagen renews slowly and remains in the skin for a long time, it is exposed to glycation and oxidation environments over extended periods. This is an important reason why AGEs can gradually accumulate in skin collagen.
2.2 How Collagen Crosslinking Manifests as Dullness, Roughness, and Fine Lines
Some AGEs have fluorescent and yellow-brown characteristics. AGE accumulation can cause collagen browning, making the skin appear more yellow and dull. AGEs can also affect collagen fiber arrangement and the balance of collagen degradation, reducing dermal elasticity and making the skin surface more prone to roughness and fine lines.
AGEs can also bind to RAGE, the receptor for advanced glycation end products, and induce responses related to ROS (reactive oxygen species), inflammatory signaling, and MMPs (matrix metalloproteinases), further aggravating collagen structural damage.
Increased AGEs → Abnormal collagen crosslinking → Restricted sliding of collagen fibers → Reduced dermal elasticity → Dullness, roughness, fine lines, and reduced rebound
3. The Structural Basis of α-Lipoic Acid: Carboxyl Group, Carbon Chain, and Disulfide Ring
3.1 What Is α-Lipoic Acid?
α-Lipoic acid, abbreviated as ALA, is also known as lipoic acid or thioctic acid. It is an endogenous sulfur-containing compound found in the human body and a disulfide derivative of octanoic acid. It acts as a cofactor in mitochondrial energy metabolism and can also participate in redox regulation.
Its chemical name is 5-(1,2-dithiolan-3-yl)pentanoic acid. Its simplified structure is shown below:

HOOC-(CH2)4-CH-(1,2-dithiolane ring)
Where:
HOOC- Carboxylic acid group
-(CH2)4- Hydrophobic carbon chain
1,2-dithiolane ring Five-membered disulfide ring containing two sulfur atoms
3.2 Its Structure Determines Three Fundamental Capabilities
Molecular structure | Chemical feature | Corresponding capability |
Carboxylic acid group -COOH | Polar, ionizable | Provides hydrophilicity, allowing the molecule to interact with aqueous environments |
Carbon chain -(CH2)4- | Nonpolar, hydrophobic | Provides lipophilicity, allowing the molecule to enter lipid environments |
Disulfide ring -S-S- | Can be reduced to two thiol groups | Forms the ALA/DHLA redox cycle and serves as the active core |
The antioxidant characteristics of α-lipoic acid come from the combined action of these three structural components:
the carboxyl group provides polarity and ionizable properties, allowing the molecule to interact with aqueous environments; the carbon chain and sulfur-containing five-membered ring provide hydrophobic characteristics, giving it the structural basis to enter lipid environments; and the disulfide bond enables participation in electron transfer.
4. The Active Core: The ALA/DHLA Redox Cycle
4.1 The Disulfide Bond Is a Reversible Redox Switch
The five-membered disulfide ring of ALA can be reduced to form DHLA, or dihydrolipoic acid. This process can be represented by a simplified half-reaction:
ALA + 2H⁺ + 2e⁻ ⇌ DHLA
In essence, the disulfide bond accepts two electrons and two protons, opens the ring, and forms two thiol groups:
R-S-S-R′ + 2H⁺ + 2e⁻ ⇌ R-SH + HS-R′
ALA:
HOOC-(CH2)4-CH-(1,2-dithiolane ring)
DHLA:
HOOC-(CH2)4-CH(SH)-CH2-CH2-SH
4.2 ALA/DHLA Acts as an Electron-Transfer Node in the Antioxidant Network
ALA and DHLA form a redox pair. After ALA accepts electrons, it is converted into DHLA, and DHLA can then transfer its reducing capacity to other oxidized molecules. This feature means that it does not merely scavenge free radicals on its own, but can also participate in regeneration cycles among antioxidants.
ALA ⇌ DHLA
Oxidized form ⇌ Reduced form
The ALA/DHLA system can scavenge certain reactive species, chelate metal ions, and influence antioxidant systems involving vitamin C, vitamin E, and GSH (glutathione). The disulfide bond is the core structure through which α-lipoic acid exerts its redox activity.
5. Distribution Advantage: Connecting Aqueous and Lipid Phases
5.1 Oxidative Reactions in the Skin Occur in Different Regions
Skin region | Environmental feature | Main oxidative risks |
Cytoplasm, extracellular fluid, dermal interstitial fluid | Aqueous environment | ROS reactions, protein oxidation, ascorbic acid depletion |
Cell membranes, lipid bilayers, sebum film | Lipid environment | Lipid peroxidation, membrane structural damage |
Mitochondria and metabolically active regions | Redox reactions are intensive | Electron leakage, ROS generation |
5.2 The Amphiphilic Nature of α-Lipoic Acid Comes from Its Molecular Structure
ALA contains both hydrophilic and lipophilic structural features.
Hydrophilic end: carboxylic acid group -COOH
Lipophilic end: carbon chain + sulfur-containing five-membered ring
Oxidative damage in the skin does not occur in only one location. Aqueous environments require water-soluble antioxidants, while lipid membranes and the sebum film require lipid-soluble antioxidant protection. What makes α-lipoic acid distinctive is that its amphiphilic structure allows it to participate in both aqueous and lipid environments, while the ALA/DHLA redox pair helps connect different antioxidant systems.
Ingredient | Main solubility feature | Main area of action | Antioxidant role |
Vitamin C | Water-soluble | Aqueous environments such as the cytoplasm, extracellular fluid, and dermal interstitial fluid | Scavenges certain water-phase ROS (reactive oxygen species) and participates in the regeneration of oxidized vitamin E |
Vitamin E | Lipid-soluble | Lipid environments such as cell membranes, the sebum film, and lipid bilayers | Captures lipid peroxyl radicals and interrupts lipid peroxidation chain reactions |
α-Lipoic acid | Amphiphilic | Can participate in both aqueous and lipid phases | Through the ALA/DHLA redox pair, connects aqueous-phase antioxidation, lipid-phase antioxidation, and the intracellular GSH (glutathione) reducing system |
The aqueous-lipid dual-phase characteristics of ALA do not mean that it is highly stable or highly soluble in every formulation. Topical skincare products still need to consider solvent systems, pH, light protection, antioxidant protection, and packaging stability. The advantage of ALA lies in the fact that its structure provides a basis for participation in redox reactions across aqueous and lipid phases.
6. The Antioxidant Network: Linking Free Radicals, Metal Ions, Vitamin C, Vitamin E, and GSH
6.1 First Layer: Reducing ROS/RNS Attacks on Proteins and Lipids
ALA/DHLA can react with various ROS and RNS (reactive nitrogen species), including hydroxyl radicals, superoxide radicals, peroxyl radicals, singlet oxygen, nitric oxide radicals, peroxynitrite, and hypochlorous acid. It should be noted that ALA and DHLA do not have identical reactivity toward different reactive species, and DHLA generally has stronger reducing capacity.
Increased ROS/RNS → Lipid peroxidation, protein oxidation, DNA damage → Glycation intermediates become more susceptible to oxidation and rearrangement → Increased pressure for AGE formation
By reducing oxidative stress, ALA/DHLA can decrease the conditions that drive glycation reactions further toward AGE formation.
6.2 Second Layer: Chelating Certain Transition Metal Ions to Reduce Metal-Catalyzed Oxidative Stress
Transition metal ions such as iron and copper can catalyze free radical generation. A typical example is the Fenton reaction:
Fe²⁺ + H₂O₂ → Fe³⁺ + ·OH + OH⁻
Here, ·OH is the hydroxyl radical, which is highly reactive and can attack lipids, proteins, and nucleic acids, leading to lipid peroxidation, protein oxidation, and cellular structural damage.
The metal-chelating capacity of ALA/DHLA is related to its sulfur atoms and carboxyl group. It is important to distinguish between ALA (α-lipoic acid) and DHLA (dihydrolipoic acid), as their metal-binding characteristics are not exactly the same: DHLA can chelate various metal ions such as Fe³⁺, Cu²⁺, Zn²⁺, Pb²⁺, and Hg²⁺; ALA can bind metal ions such as Mn²⁺, Cu²⁺, Zn²⁺, and Pb²⁺, but has relatively weak chelating ability toward Fe³⁺. Metal chelation does not mean depletion of metal elements in the skin; rather, it reduces the opportunity for free metal ions to participate in redox catalysis, thereby reducing metal-catalyzed oxidative stress.
Fe/Cu and other metal ions → Catalyze ROS generation → Increased lipid peroxidation and protein oxidation → Glycation intermediates more readily convert into AGEs
ALA/DHLA chelates some metal ions → Reduced metal-catalyzed oxidative stress → Reduced promoting factors for AGE formation
6.3 Third Layer: Helping Vitamin C and Vitamin E Enter Regeneration Cycles
Vitamin E is mainly present in lipid environments, such as cell membranes, lipid bilayers, and the sebum film. Its core function is to protect lipid structures. When lipids are attacked by oxidation, lipid peroxyl radicals are generated; vitamin E can preferentially react with these radicals, blocking the further spread of lipid peroxidation and thereby protecting cell membranes and skin lipid structures.
During this process, vitamin E “gives away” its reducing capacity and changes from its active state into an oxidized vitamin E radical. In other words, after vitamin E completes one round of antioxidant protection, it temporarily loses part of its antioxidant capacity.
At this point, vitamin C can participate in repair. Vitamin C is mainly present in aqueous environments, where it can reduce oxidized vitamin E back to its active form, allowing vitamin E to continue protecting lipid membranes. This process reflects the synergy between aqueous-phase and lipid-phase antioxidants: vitamin E intercepts lipid radicals in the lipid phase, while vitamin C helps regenerate vitamin E in the aqueous phase.
What is distinctive about α-lipoic acid is that its reduced form, DHLA (dihydrolipoic acid), can further support the vitamin C system. DHLA has reducing capacity and can help restore oxidized vitamin C to its reduced state, allowing vitamin C to continue participating in antioxidant cycling. In this way, DHLA, vitamin C, and vitamin E form a continuous antioxidant regeneration chain.
This process can be understood as follows:
DHLA helps vitamin C restore its reducing capacity;
Vitamin C helps vitamin E regain activity;
Vitamin E continues to protect lipid membranes and block lipid peroxidation.
6.4 Fourth Layer: Supporting the GSH System and Maintaining the Cellular Reducing State
GSH (glutathione) is an important intracellular reducing system composed of glutamic acid, cysteine, and glycine. It participates in peroxide clearance, maintains the thiol status of proteins, and helps cells preserve a reducing environment.
ALA may increase or maintain intracellular GSH levels by promoting the expression of genes related to GSH synthesis and increasing substrate availability. ALA/DHLA may also support the cellular antioxidant state by influencing the GSH/GSSG ratio, where GSSG refers to glutathione disulfide, the oxidized form of glutathione.
GSH is also involved in the metabolism of dicarbonyl compounds. MGO is an important reactive dicarbonyl compound involved in AGE formation, and the human body can process MGO through the glyoxalase system. This system involves GLO1 (glyoxalase 1), GLO2 (glyoxalase 2), and GSH. By supporting the GSH/GSSG status and the cellular reducing environment, ALA may theoretically help cells respond to carbonyl stress from compounds such as MGO.
MGO is a reactive carbonyl compound that readily promotes glycation
↓
GSH first binds with MGO to form a temporary intermediate
↓
GLO1 and GLO2 sequentially process this intermediate
↓
MGO is converted into D-lactate
↓
GSH is released and continues to participate in the cellular redox cycle
6.5 Mechanistic Overview
Layer of action | α-Lipoic acid-related structure | Main mechanism | Relationship to anti-glycation |
Free radical scavenging | ALA/DHLA redox pair | Neutralizes certain ROS/RNS | Reduces oxidation, rearrangement, and crosslinking of glycation intermediates |
Metal chelation | Sulfur atoms + carboxyl group | Reduces opportunities for Fe/Cu and other metals to catalyze oxidation | Reduces metal-catalyzed glycoxidation and protein oxidation |
Vitamin C / vitamin E regeneration | Reducing capacity of DHLA | Helps maintain vitamin C in its reduced form and indirectly supports the vitamin E cycle | Maintains antioxidant continuity between aqueous and lipid phases |
GSH support | ALA regulation of cellular redox state | Maintains GSH/GSSG balance and supports cellular antioxidant defense | Indirectly supports the handling of MGO and other carbonyl stresses |
Aqueous-lipid dual-phase distribution | Carboxyl group + carbon chain + disulfide ring | Connects aqueous phases, lipid phases, and intracellular reducing systems | Covers a broader range of oxidative damage regions |
7. Skincare Application: The Practical Value of α-Lipoic Acid in Anti-Glycation and Anti-Aging
7.1 Point of Intervention: Reducing the Environmental Pressure That Drives Continued Glycation
When α-lipoic acid is used in anti-aging skincare, the focus is not on directly eliminating already-formed AGEs, but on reducing the oxidative environment and catalytic conditions required for glycation to continue progressing.
Already-formed AGE crosslinks are generally relatively stable, and collagen is a low-turnover, long-lived structural protein. The more realistic role of topical α-lipoic acid is to help reduce new oxidative damage, metal-catalyzed oxidation, and carbonyl stress, thereby lowering the risk of continued abnormal collagen crosslinking, rather than immediately restoring collagen that has already been fixed by glycation to a youthful structure.
Direction of action | Significance for glycation-related aging |
Reducing oxidative stress | Reduces the conditions that promote further oxidation, rearrangement, and crosslinking of glycation intermediates |
Chelating certain metal ions | Reduces the opportunity for iron, copper, and other metal ions to participate in redox catalysis |
Supporting antioxidant regeneration cycles | Helps vitamin C, vitamin E, and GSH (glutathione) systems maintain reducing capacity |
Assisting in carbonyl stress control | By supporting the cellular reducing environment, indirectly reduces the modification pressure exerted by reactive carbonyl compounds on proteins |
7.2 Human Study: Improvement of Photoaging-Related Roughness with 5% α-Lipoic Acid
Topical 5% α-lipoic acid has some support from human research. A split-face controlled study enrolled 33 women: one side of each participant’s face was treated twice daily with a 5% α-lipoic acid cream, while the other side was treated with an identical vehicle cream without α-lipoic acid, for 12 weeks. The study used self-assessment, clinical evaluation, photographic assessment, and laser profilometry for observation. The results showed improvement in photoaging-related manifestations on the α-lipoic acid-treated side. Laser profilometry showed that average skin roughness decreased by 50.8% on the α-lipoic acid side and by 40.7% on the control side, with a statistically significant difference between the two sides.
These results support the potential of topical 5% α-lipoic acid to improve photoaging-related skin roughness, texture, and fine-line appearance. However, the study had a small sample size, and the control side also showed noticeable improvement, indicating that the cream vehicle, moisturization, and consistent use can also influence skin texture. This study did not directly measure skin AGEs, collagen glycation crosslinking, or carbonyl stress markers, and therefore cannot be considered strong evidence that topical α-lipoic acid has been clinically proven to be anti-glycation.
7.3 Formulation Positioning
Formulation positioning | Main role of α-lipoic acid |
Antioxidant care | Participates in controlling reactive oxygen stress and reduces the impact of oxidative damage on skin structural proteins |
Anti-glycation support | Reduces the driving effects of oxidative stress, metal catalysis, and carbonyl stress on AGE formation |
Photoaging care | Topical research supports its potential benefits for photoaging-related roughness and fine-line appearance |
Composite antioxidant system | Can form an antioxidant regeneration logic with systems related to vitamin C, vitamin E, and glutathione |
Collagen environment protection | By reducing the damaging environment, helps reduce abnormal collagen crosslinking and degradation pressure |
8. Representative Chemical Product Classification Tables Related to the Anti-Aging Mechanisms of α-Lipoic Acid
Table 1. Core Products Related to α-Lipoic Acid Structure and Redox Cycling
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Parent lipoic acid compound | 1077-28-7 | DL-Lipoic Acid | ≥99% | Main racemic lipoic acid raw material, used in studies related to disulfide ring structure, redox cycling, antioxidant activity, and intervention in protein glycation | |
Chiral lipoic acid compound | 1200-22-2 | (R)-(+)-α-Lipoic Acid | Moligand™, ≥98% | Naturally configured lipoic acid, used for comparing the activity of chiral lipoic acid forms, studying mechanisms related to mitochondrial cofactors, and investigating intervention in oxidative and glycation stress | |
Reduced-form lipoic acid compound | 462-20-4 | Dihydrolipoic Acid | Moligand™, ≥97% | Reduced form of lipoic acid, used in studies of thiol-based reducing capacity, ascorbic acid regeneration, tocopherol regeneration, and glutathione cycling | |
Lipoylation-related compound | 940-69-2 | (±)-α-Lipoamide | Moligand™, ≥98% | Amide form of lipoic acid, used in studies of lipoylated cofactors, mitochondrial enzyme complexes, energy metabolism, and redox reactions |
Table 2. Products for Glycation Reactions, Carbonyl Stress, Glycation Markers, and Anti-Glycation Research
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Glycation substrate | 50-99-7 | D-(+)-Glucose | Anhydrous grade, UltraBio™, ≥99.5% (HPLC), sum of enantiomers | Typical reducing sugar substrate, used in protein glycation models, Schiff base formation, Amadori product formation, and collagen glycation reaction studies | |
Glycation substrate | 57-48-7 | D-(-)-Fructose | UltraBio™, ≥99% (HPLC) | Reducing sugar substrate, used for comparing glycation reaction rates, protein glycation models, and glycation stress evaluation | |
Reactive dicarbonyl compound | 107-22-2 | Glyoxal Solution | Molecular biology grade, 40% in H2O (8.8 M) | Reactive dicarbonyl reagent, used in studies of protein carbonylation, lysine modification, and advanced glycation end product formation | |
Reactive dicarbonyl compound | 78-98-8 | Methylglyoxal | Moligand™, 40% solution | Methylglyoxal reagent, used in carbonyl stress models, protein modification studies, and evaluation of anti-carbonylation activity | |
Glycation intermediate | 4084-27-9 | 3-Deoxyglucosone | — | Highly reactive glycation intermediate, used in studies of Amadori product degradation, carbonyl stress, and advanced glycation end product formation | |
Advanced glycation end product marker | 5746-04-3 | Nε-(1-Carboxymethyl)-L-lysine | ≥98% | Non-fluorescent glycation marker, used in studies of protein glycoxidation, collagen glycation level, and glycation damage detection | |
Crosslinking glycation marker | 124505-87-9 | Pentosidine | — | Fluorescent crosslinking glycation marker, used in studies of collagen crosslinking, glycation-related yellowing, and skin aging indicator detection | |
Anti-carbonylation active compound | 305-84-0 | L-Carnosine | Moligand™, ≥98% | Dipeptide anti-carbonylation compound, used in studies of reactive carbonyl trapping, protein glycation inhibition, and collagen protection | |
Anti-glycation positive control | 1937-19-5 | Aminoguanidine Hydrochloride | Moligand™, ≥98% (T) | Classical anti-glycation research reagent, used for dicarbonyl compound trapping, advanced glycation end product inhibition, and positive control experiments | |
Anti-glycation positive control | 2582-30-1 | Aminoguanidine Bicarbonate | ≥98.5% | Aminoguanidine salt reagent, used for carbonyl trapping, glycation reaction inhibition, and validation of anti-glycation mechanisms | |
Vitamin B6-related anti-glycation compound | 85-87-0 | Pyridoxamine | ≥98% | Vitamin B6-related compound, used in studies of dicarbonyl compound intervention, metal-related glycoxidation reactions, and protein glycation inhibition | |
Vitamin B6-related anti-glycation compound | 524-36-7 | Pyridoxamine Dihydrochloride | ≥98% | Salt form of pyridoxamine, used in studies of carbonyl stress intervention, glycoxidation inhibition, and anti-glycation activity evaluation |
Table 3. Products Related to the Antioxidant Regeneration Network, Aqueous-Phase Antioxidation, and Lipid-Phase Antioxidation
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Prototype aqueous-phase antioxidant | 50-81-7 | L-Ascorbic Acid | Anhydrous grade, Moligand™, ACS, ≥99% | Representative water-soluble antioxidant, used in studies of ascorbic acid redox cycling, free radical scavenging, and tocopherol regeneration | |
Water-soluble stable ascorbic acid derivative | 86404-04-8 | 3-O-Ethyl-L-ascorbic Acid | Moligand™, ≥98% (HPLC) (T) | Stable ascorbic acid derivative, used in studies of aqueous-phase antioxidation, ascorbic acid release, and skin-brightening-related evaluation | |
Water-soluble stable ascorbic acid derivative | 113170-55-1 | L-Ascorbic Acid 2-Phosphate Sesquimagnesium Salt Hydrate | Moligand™, ≥98% (HPLC) | Magnesium ascorbyl phosphate, used in stable ascorbic acid systems, aqueous-phase antioxidation, and cell-based experiments | |
Water-soluble stable ascorbic acid derivative | 66170-10-3 | Trisodium L-Ascorbate-2-Phosphate | ≥96% | Sodium ascorbyl phosphate, used in aqueous-phase antioxidation, evaluation of stable ascorbic acid activity, and cell culture-related experiments | |
Water-soluble stable ascorbic acid derivative | 129499-78-1 | 2-O-α-D-Glucopyranosyl-L-ascorbic Acid | ≥98% (HPLC) | Ascorbyl glucoside, used in stable ascorbic acid systems, enzymatic release studies, and antioxidant activity research | |
Lipid-soluble ascorbic acid derivative | 137-66-6 | L-Ascorbyl Palmitate | PharmPure™, USP | Lipid-soluble ascorbic acid ester, used in lipid-environment antioxidation, ascorbic acid and tocopherol synergy, and oil-phase formulation research | |
Lipid-soluble ascorbic acid derivative | 183476-82-6 | Ascorbyl Tetraisopalmitate | Cosmetic grade, ≥90% | Oil-soluble ascorbic acid derivative, used in lipid-phase antioxidation, skin lipid environments, and composite antioxidant formulation research | |
Prototype lipid-phase antioxidant | 59-02-9 | D-α-Tocopherol | Moligand™, ≥97% (GC) | Representative lipid-soluble antioxidant, used in studies of lipid peroxidation chain reaction inhibition, cell membrane protection, and antioxidant regeneration cycling | |
Stable tocopherol derivative | 7695-91-2 | DL-α-Tocopheryl Acetate | PharmPure™, European Pharmacopoeia (Ph. Eur.) | Stable tocopherol derivative, used in lipid-phase antioxidant formulations, skin conditioning, and tocopherol-related control studies | |
Glutathione reducing system | 70-18-8 | Glutathione, Reduced Form | PharmPure™, European Pharmacopoeia (Ph. Eur.) | Reduced glutathione, used in studies of the cellular reducing environment, peroxide clearance, carbonyl stress handling, and antioxidant cycling | |
Glutathione reducing system | 27025-41-8 | L-Glutathione, Oxidized Form | ≥98% | Oxidized glutathione, used in studies of the glutathione redox ratio, cellular redox state, and antioxidant cycling | |
Lipid-phase quinone antioxidant | 303-98-0 | Coenzyme Q10 | ≥98% | Lipid-phase quinone antioxidant, used in studies of mitochondrial redox activity, lipid antioxidation, and cellular energy metabolism | |
Phenolic acid antioxidant | 1135-24-6 | Ferulic Acid | Moligand™, ≥99% | Phenolic acid antioxidant, used in studies of free radical scavenging, photo-oxidative protection, and antioxidant combination systems | |
Polyphenol antioxidant | 501-36-0 | Resveratrol | Moligand™, ≥99% | Polyphenol antioxidant, used in studies of oxidative stress regulation, photoaging-related research, and construction of composite antioxidant systems |
Table 4. Products Related to Metal-Catalyzed Oxidation, Oxidative Stress Models, and Skin Structural Proteins
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Oxidative stress model compound | 7722-84-1 | Hydrogen Peroxide Solution | Suitable for microbiology, 3% | Oxidative stress-inducing reagent, used in peroxide stimulation, cellular oxidative damage, and antioxidant activity evaluation | |
Metal ion chelator | 6381-92-6 | Ethylenediaminetetraacetic Acid Disodium Salt Dihydrate | UltraBio™, ultrapure grade, ≥98.5% | Common metal ion chelator, used in metal-catalyzed oxidation control, formulation stabilization, and oxidative reaction intervention experiments | |
Polyphosphate metal chelator | 83-86-3 | Phytic Acid Solution | 70% in H2O | Polyphosphate-structured chelator, used for binding iron, copper, and other metal ions, inhibiting metal-catalyzed oxidation, and formulation stabilization research | |
Polyphosphate metal chelator | 14306-25-3 | Phytic Acid Sodium Salt Hydrate | ≥75% | Phytate chelator, used for aqueous-phase metal ion control, oxidative catalysis inhibition, and antioxidant formulation research | |
Collagen glycation model protein | 9007-34-5 | Recombinant Humanized Type III Collagen | Animal-free, carrier-free, recombinant, ≥90% (SDS-PAGE), expressed in Nicotiana benthamiana | Collagen structural protein model, used in studies of collagen glycation, collagen crosslinking, structural aging, and collagen protection | |
Elastin aging model | 9007-58-3 | Porcine Elastin | ≥90% | Elastic structural protein model, used in studies of elastin glycation, oxidative damage, loss of elasticity, and skin mechanical aging |
Note: The above are representative Aladdin products related to scientific research and formulation studies. For more product specifications, grades, and COA information, please search by “product name / CAS / catalog number” on the Aladdin official website.
For more related articles, please see below:
Role of Sphingolipid Metabolic Remodeling in Apoptotic and Inflammatory Signaling
How to decipher the whitening code?
Niacin (Vitamin B3): Structural Features, Metabolic Roles, and Application Landscape
The "Six Key Checkpoints" of Skin Lightening
Tyrosinase: a key regulatory enzyme in melanin synthesis and its biological and applied significance
危险品化学品经营许可证(带存储)